MS
Highly rated in
2
conditions
Highly rated in
2
conditions

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

About Dr. Maria Satta-Alvarez

Maria Satta-Alvarez is in Vigo, Spain. Dr. Satta-Alvarez is highly rated in 2 conditions, according to our data. Her top areas of expertise are Bardet-Biedl Syndrome, Polydactyly, Cone-Rod Dystrophy, and Late-Onset Retinal Degeneration.

Her clinical research consists of co-authoring 12 peer reviewed articles in the past 15 years.

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Locations
  Vigo, GA 36310, ES
Background & Education
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
University Hospital Of Vigo
 
Vigo, GA, ES 36215
 0.1 km
Irene Vieitez-Vietez is in Vigo, Spain. They have been an author on 17 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
University Hospital Complex Of Vigo
 
Vigo, GA, ES 
 0.1 km
Jose Reigosa-Pego is in Vigo, Spain. They have been an author on 80 peer reviewed articles and participated in 1 clinical trial in the past 15 years.
Highly rated in
0
conditions
University Of Vigo
 
Vigo, GA, ES 36310
 0.1 km
Ramon Hermida is in Vigo, Spain. They have been an author on 124 peer reviewed articles and participated in 12 clinical trials in the past 15 years.